Yahoo Finance

Operations: Revenue segment information for Jiangsu Huifeng Bio Agriculture Co., Ltd. is not reported.

Market Cap: CN¥3.32B

Jiangsu Huifeng Bio Agriculture Co., Ltd. reported sales of CN¥153.56 million for the nine months ending September 2024, with a net income of CN¥1.3 million, marking an improvement from a significant loss the previous year. Despite this, the company remains unprofitable and has seen earnings decline over five years at 5.1% annually. Short-term assets cover long-term liabilities but fall short against short-term liabilities of CN¥906.4 million, indicating liquidity challenges despite having reduced its debt-to-equity ratio significantly over five years to 21.8%. The management team is relatively new with an average tenure of 1.8 years.

• Click here to discover the nuances of Jiangsu Huifeng Bio Agriculture with our detailed analytical financial health report.

• Assess Jiangsu Huifeng Bio Agriculture's previous results with our detailed historical performance reports.

Era

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Era Co., Ltd. is engaged in the research, development, production, and sale of plastic pipe products in China with a market cap of CN¥5.62 billion.

Operations: No revenue segments have been reported for Era Co., Ltd.

Market Cap: CN¥5.62B

Era Co., Ltd. has shown a reduction in its debt-to-equity ratio from 7.1% to 2.7% over the past five years, indicating improved financial management. The company’s short-term assets of CN¥4 billion comfortably cover both short-term and long-term liabilities, suggesting strong liquidity. Despite this, Era's net income for the nine months ending September 2024 dropped significantly to CN¥147.74 million from CN¥278.32 million a year ago, with earnings per share halving during this period. Although the company maintains high-quality earnings and is forecasted to grow profits by 22.5% annually, recent performance highlights challenges in sustaining profitability amidst declining revenue figures.

• Take a closer look at Era's potential here in our financial health report.

• Evaluate Era's prospects by accessing our earnings growth report.

Where To Now?

• Take a closer look at our Penny Stocks list of 5,773 companies by clicking here.

• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.

• Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Jump on the AI train with fast growing tech companies forging a new era of innovation.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SHSE:600725 SZSE:002496 and SZSE:002641.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com